News &
Media
Neurotech International: Quarterly Investor Conference Call – Q4 FY23
View MoreListen to the audio here | Time: 22.10
Neurotech International: Quarterly Investor Conference Call with Dr Thomas Duthy for the period ending 31 March 2023
View MoreListen to the audio here | Time: 17.45
Small Caps Inverview: Neurotech International advances novel treatment for autism spectrum disorder
View MoreWatch the presentation here | Time: 22:15
NWR Virtual Healthcare Conference Presentation: Neurotech International Investor Presentation
View MoreWatch the presentation here | Time: 28:10
Neurotech International: 52 Week Phase I/II Autism Clinical Trial Data Presentation with Dr Thomas Duthy
View MoreWatch the presentation here | Time: 25:45
Neurotech International: Quarterly Investor Conference Call with Dr Thomas Duthy
View MoreListen to the audio here | Time: 14.21
SBS News: New study examines medicinal cannabis treatment for people with autism
View MoreListen to the episode here | Time: 5.02
Sydney Morning Herald: Medicinal cannabis shows promising results for children with autism
View MoreA groundbreaking new trial of medicinal cannabis has uncovered some promising results for families of children living with autism
7NEWS: Medical cannabis trial for children living with Autism
View More